Bayer To Pay $10 Billion+ To Resolve Roundup Cancer Lawsuits
In June 2020, Roundup maker Bayer AB announced a blockbuster $10 billion dollar settlement to resolve cancer lawsuits connected to its weedkiller Roundup.
This after Bayer faced tens of thousands of cases linking the active ingredient in RoundUp- a chemical called glyphosate- to increased risk of developing Non Hodgkins Lymphoma.
Lawsuits that sent Bayer AB's shares sharply downward.
To put this trouble behind them, Bayer's $8.8 billion to $9.6B deal covers approximately 95,000 cases.
It also provides an additional $1.25B for future cases.
Bayer still faces 30,000+ cases from plaintiffs who have not agreed to participate in the settlement.